Pain Management

FDA's AdComm Says Avenue Therapeutics Submitted Insufficient Data On IV Tramadol

Medtronic's Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief

FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study

Medtronic's Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief

FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study

Read Why Shares Of Nano Cap Cumberland Pharma More Than Doubled

Singapore Based iX Biopharma Hands Seelos Exclusive Rights For Wafermine For Pain Management

Read Why Shares Of Nano Cap Cumberland Pharma More Than Doubled

Singapore Based iX Biopharma Hands Seelos Exclusive Rights For Wafermine For Pain Management

Adial Pharma-Backed Purnovate Selects PNV-5030 As Pain Management Candidate

Venus Concept's Pain Management Device Scores FDA Nod

Pain Management Recent News

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

NanoVibronix Launches CBD-Based Product For Pain Management

Why Is Flexion Therapeutics (FLXN) Stock Gaining On Wednesday?

Flexion Therapeutics Inc (NASDAQ: FLXN) expanded the Phase 1b trial of FX301 in patients undergoing bunionectomy.

NanoVibronix Shares Soar On Its Plans To Enter OTC Pain-Relief Market

A Q&A With Abacus Health Products, The CBD Company Backed By Rob Gronkowski

AcelRx Shares React Positively To Tepid FDA Comments On Painkiller Candidate Dsuvia

Cara Therapeutics' 15% Surge, Explained

Exclusive: Egalet CFO Talks 'Hot Button' Rx Abuse-Deterrence, Pipeline And Multimillion-Dollar Financing

Can Marijuana Fight America's Drug Addiction?

;